Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients.

"Declarations Conflict of interestGGG, JF, EL, GB and VR report no conflicts of interest. JKL has received speaker fees from Dr. Falk pharmaceuticals. SS has received speaker fees from Abbvie, Dr. Falk pharmaceuticals, Takeda, Janssen, Celltrion, Bristol-Myers Squibb and received educational grants from Abbvie, Takeda and Janssen and is an advisory board member for Abbvie, Dr. Falk pharmaceuticals, Vifor pharmaceuticals, Janssen, Takeda and Celltrion. SS is an associate editor for AP&T. PKF received a Shire Innovation Fund award and has received funded conference travel from Shire and Tillotts. PJS has received speaker fees from Takeda, Janssen, Celltrion, Abbvie, Amgen, Dr. Falk pharmaceuticals, Tillotts Pharma and has been an advisory board member for Abbvie, Celltrion and Janssen. EL has received speaker fees from Janssen and a research grant from Galapagos. CPS has received unrestricted research grants from Abbvie and Janssen, has provided consultancy to Arena, Galapagos, Dr. Falk, Fresenius Kabi, Abbvie, Janssen and Takeda, and had speaker arrangements with Janssen, Dr. Falk, Abbvie, Pfizer and Takeda. All authors approve the final version of the manuscript. Conflict of interest GGG, JF, EL, GB and VR report no conflicts of interest. JKL has received speaker fees from Dr. Falk pharmaceuticals. SS has received speaker fees from Abbvie, Dr. Falk pharmaceuticals, Takeda, Janssen, Celltrion, Bristol-Myers Squibb and received educational grants from Abbvie, Takeda and Janssen and is an advisory board member for Abbvie, Dr. Falk pharmaceuticals, Vifor pharmaceuticals, Janssen, Takeda and Celltrion. SS is an associate editor for AP&T. PKF received a Shire Innovation Fund award and has received funded conference travel from Shire and Tillotts. PJS has received speaker fees from Takeda, Janssen, Celltrion, Abbvie, Amgen, Dr. Falk pharmaceuticals, Tillotts Pharma and has been an advisory board member for Abbvie, Celltrion and Janssen. EL has received speaker fees from Janssen and a research grant from Galapagos. CPS has received unrestricted research grants from Abbvie and Janssen, has provided consultancy to Arena, Galapagos, Dr. Falk, Fresenius Kabi, Abbvie, Janssen and Takeda, and had speaker arrangements with Janssen, Dr. Falk, Abbvie, Pfizer and Takeda. All authors approve the final version of the manuscript."

"Funding This research was not directly funded."